Symbicort pMDI
Sponsors
AstraZeneca
Conditions
AsthmaBronchial Asthma
Phase 3
Symbicort Rapihaler Therapeutic Equivalence Study
CompletedNCT00536731
Start: 2007-09-30End: 2008-04-30Updated: 2012-08-15
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
CompletedNCT01444430
Start: 2011-12-31End: 2015-10-31Updated: 2016-12-15
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
CompletedNCT02091986
Start: 2014-04-30End: 2016-04-30Updated: 2017-04-10